# Neosoma, Inc.

- Location (FDA's records): Groton, MA
- FDA decisions: 2 (2022–2025): 2 510(k) clearances
- Product codes: QIH (2)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cortechs Labs, Inc.: 1 (https://510kreport.com/company/cortechs-labs)
- Vysioneer, Inc.: 1 (https://510kreport.com/company/vysioneer)

## Firms that cite its devices most
- Mrimath, LLC: 1 (https://510kreport.com/company/mrimath)
- Roche Molecular Systems, Inc.: 1 (https://510kreport.com/company/roche-molecular-systems)
- Cercare Medical A/S: 1 (https://510kreport.com/company/cercare-medical-a-s)

## Its most-cited devices
- K221738: NS-HGlio (2022), cited by 3

## Recent decisions
- K252922: Neosoma Brain Mets (Dec 17, 2025)
- K221738: NS-HGlio (Sep 27, 2022)

Source page: https://510kreport.com/company/neosoma